Reaction

Tunnel Vision reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,836 reports · 30 co-occurring drugs

As of the last recalculation, Tunnel Vision appears in 1,836 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS (PRR 31.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Diltiazem Hydrochloride Extended-Release Tablets3131.431.5
Mometasone4025.225.3
Theophylline1413.913.9
Theophylline Anhydrous1513.813.8
Naltrexone Hydrochloride And Bupropion Hydrochloride1013.413.4
Diltiazem Hydrochloride3511.711.7
Omalizumab8011.111.1
Metformin Hydrochloride Tablets5310.810.8
Metformin Hydrochloride Extended-Release Tablets5310.810.8
Metformin Hydrochloride Tablet5310.810.8
Mometasone Furoate3810.510.5
Metformin Hydrochloride5310.410.4
Atorvastatin Calcium, Film Coated498.18.1
Agalsidase Beta67.47.4
Pegvaliase-Pqpz56.96.9
Piperacillin Sodium,Tazobactam Sodium166.96.9
Vilazodone Hydrochloride56.26.2
Vigabatrin75.55.5
Encorafenib44.64.6
Asfotase Alfa44.54.5
Ofatumumab134.54.5
Cenobamate34.14.1
Acetaminophen, Aspirin (Nsaid) And Caffeine64.04.0
Fremanezumab-Vfrm44.04.0
Glatiramer Acetate203.83.8
Rimegepant Sulfate43.63.6
Medroxyprogesterone Acetate143.23.2
Esketamine Hydrochloride42.52.5
Levonorgestrel281.61.6
Valbenazine31.41.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.